Prica, A., Hay, A. E., Crump, M., Mittmann, N., Shepherd, L. E., Meyer, R. M., . . . Cheung, M. C. (2021). Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial. Curr Oncol.
Citação norma ChicagoPrica, Anca, et al. "Evaluating the Indirect Costs of Care Associated With Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial." Curr Oncol 2021.
Citação norma MLAPrica, Anca, et al. "Evaluating the Indirect Costs of Care Associated With Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial." Curr Oncol 2021.